bpc 157 post surgery dosage BPC-157 Protocol: Injection Guide BPC-157 Dosage: Dosing, Safety &

Tendon gap closure, measured macroscopically in rupture models, is complete or near complete in BPC-157 groups at time points when untreated tendons retain visible defects

Sustained high levels of parathyroid hormone, as seen in hyperparathyroidism, stimulate osteoclasts and lead to net bone loss and hypercalcemia

BPC-157 appears to accelerate this cellular traffic pattern

BPC-157 has a molecular weight of approximately 1,419 Da on the larger end for nasal mucosal absorption which may constrain bioavailability compared to smaller peptides like Semax (which weighs 604 Da and is specifically designed for nasal delivery).8 Who nasal delivery may be relevant for (research context): Neurological or brain-adjacent applications Patients for whom injection is contraindicated Situations requiring rapid onset with non-invasive administration Research protocols studying nose-to-brain peptide pathways What to be realistic about: No peer-reviewed human trials on intranasal BPC-157 exist as of 2026 Nasal absorption of BPC-157 is less predictable than for smaller peptides Dosing standardisation for nasal BPC-157 is not established Consult a licensed provider before considering this route Peptide Delivery Method Comparison Table How to Choose the Right BPC-157 Delivery Method for Your Goal Matching the delivery method to the clinical goal is the single most important decision in BPC-157 therapy

If you are curious about how quickly semaglutide starts working , most people notice appetite changes within the first week or two, though meaningful weight loss takes longer to appear on the scale